2024年11月15日 · VBI’s vaccine and immunotherapeutic candidates are representative of the evolving science of virus-like particles. Our candidates have been rationally designed to leverage the innate power of the human immune system by closely mimicking the natural presentation of viruses, which, in turn, elicits a natural and potent immune response.

Utilising world-class technologies in protein science, VVBI focuses on developing/commercialising antibody fragment drugs, antibody/antibody fragment-drug conjugates, structure-based drug design (SBDD), fragment-based drug design (FBDD), affinity selection mass spectrometry (ASMS) screening technology, and membrane protein targeted drug discovery.

Holding Limited, TIANL Holding Limited and VVBI Limited is indirectly wholly-owned by Intertrust (Singapore) Ltd. as the trustee of the VVBI Trust (whose interest is held through VVBI Holdings Limited). Each of the Z&M Trust and the VVBI Trust is a revocable family trust set up by Ms. Mao Jun as settlor and protector. Ms.

VVBI Limited information, includes incorporation date, status, type, directors, address, contacts & more.

2023年11月14日 · 毛隽 博士 （vvbi公司 创始人）表示： 我们在2023年将维眸生物（香港）引入香港科技园，并协助公司获得新药研发的资金和资源支持。非常高兴维眸生物（香港）获得香港科技园的临床转化促成（“ctc”）计划资助，我们将和维眸生物（香港）一道积极为建设 ...

Viva Ventures Biotech Fund invests in early stage, first-in-class, drug discovery startups in large scale. We have partnered with a team of renowned entrepreneurial scientists to deliver high returns with minimal risk to qualified investors. More about us：www.vivaventuresbiotech.com.

2023年11月14日 · VVN461滴眼液是一种强效的小分子免疫调节剂，高活性抑制多个细胞因子（cytokine）通路，从而减轻和缓解眼部的炎症反应。 该资助来自香港科技园临床转化促成（“CTC”）计划，CTC计划是一个高度专业化的平台，旨在促进创新、点燃希望的治疗方案和医疗技术走向临床，为生物医学企业在临床前和早期临床阶段提供全方位支援。 该项计划致力于促进临床转化，将创新、改变生命的治疗方案和技术带给患者，推进可能改善患者生活的创新疗法和 …

2025年3月15日 · VBI is niet enkel de koepelvereniging voor alle imkerverenigingen in Vlaanderen. Het is de vereniging waar plaats is voor alle bijenliefhebbers.

2022年3月24日 · Missing features - these features from Dolphin Official are not implemented. This codebase is roughly equivalent to the Official Dolphin development build 5.0-21259 (Mar 22, 2024). For more information about what has changed check the PR history. General information. Android developers willing to help are welcome!

VVBI利用在蛋白质科学领域的世界领先技术，致力于生物技术的研发和商业化，包括抗体或抗体片段药物、抗体/抗体片段药物偶联。 此外，我们以基于结构的药物发现技术（SBDD）、基于片段的药物发现技术（FBDD）、质谱亲和筛选技术（ASMS），膜蛋白靶标药物发现技术，开展小分子化合物筛选与新药研发。 VVBI服务还包括靶点验证、苗头合物筛选、先导化合物的发现/验证、体外生物模型构建以及成药性抗体发现。 领先的开放式创新驱动技术平台，帮助生物科技企业 …